Drug development
Abivax develops and tests medicines that act on the immune system, with a focus on inflammatory and chronic diseases. Its work centers on advancing drug candidates through laboratory research and clinical trials until they can be approved and sold.
Customers
Patients with inflammatory or chronic diseases are the end users, while doctors, hospitals, and drug regulators are the groups that decide whether the medicines can be used.
Revenue Model
The company can earn money through collaboration and licensing deals during development, and later through sales of approved medicines or royalty income if partners commercialize them.